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1. Introduction 
The secretion of gonadotropins from the anterior 
pituitary is regulated by the hypothalamic linear deca- 
peptide gonadotropin-releasing hormone (GnRH). 
Peptidases that cleave GnRH may play a role in deter- 
mining the physiological levels of the neurohormone 
at the sites of its release (hypothalamus) and of its 
action (anterior pituitary). Studies on the pathways 
of GnRH degradation may shed some light on the 
physiological mechanisms controlling the secretion 
and action of GnRH as well as assist in designing long- 
acting analogues of the neurohormone. 
The initial site of degradation of GnRH by hypo- 
thalamic enzymes is the Gly6-Leu7 bond [ 11. Here 
we describe the degradative pattern of GnRH by a 
soluble fraction of the anterior pituitary and compare 
some characteristics of the degradation processes 
caused by the cytosolic fractions derived from the 
pituitary and the hypothalamus. 
2. Materials and methods 
GnRH was a generous gift of Ayerst ResearchLab- 
oratories (Montreal). [pyrogZ~tamyZ-3-3H]GnRH was 
purchased from New England Nuclear (Boston). The 
following reagents were used: bacitracin (Sigma Chem- 
ical Co., St. Louis); diisopropylfluorophosphate, 
p-chloromercuribenzoate andNethylmaleimide (Merk, 
Darmstadt); 1 ,l O-phenanthroline (Aldrich Chemical 
Corp., Milwaukee). 
2.1. Enzyme preparations 
Anterior pituitaries or the medial basal part of hypo- 
thalami from 5 rats (40-50 mg wet wt .) were detached 
ElsevierlNorth-Holland Biomedical Press 
immediately after decapitation and immersed in a 
Thomas homogenizer containing 1 ml of phosphate- 
buffered saline (PBS, pH 6.9). The tissue was homog- 
enized by applying 10 strokes with a Teflon pestle and 
spun for 30 min at 100 000 X g. The resulting super- 
natant fraction was made up to a concentration of 
30 mg wet wt. tissue/ml. Protein content of the prep- 
aration was determined as in [2]. 
2.2. Assay of degradation 
Samples of different dilutions of the supernatant 
fractions were incubated as in [l] with 1 pg GnRH in 
1 ml of 0.05 M PBS at 37°C; incubations were termi- 
nated by boiling for 3 min. The samples were then 
spun for 30 min at 17 000 X g and the supernatant 
was taken for determination of GnRH by radioimmu- 
noassay or biological assay [33. When the effects of 
pH on enzymic activities were studied, the pH was 
adjusted with 2 M HCl or 2 M NaOH. 
For electrophoresis and amino acid analysis, the 
supernatant fractions (derived from 27 mg wet wt. 
anterior pituitaries) were incubated for 10 min with 
0.8 /&i of [3H]GnRH diluted with 1 .O mg of the 
unlabeled hormone. This short period of reaction was 
selected in order to enable the detection of the initial 
site of degradation of the neurohormone. After termi- 
nating the reaction by boiling, the samples (1 ml) were 
spun for SO min at 100 000 X g, filtered through a 
Diaflo UM2 membrane (Amicon Corp. Lexington), 
lyophilized and redissolved in 0.2 ml distilled water. 
Electrophoresis was carried on Whatman No. 3 paper 
(prewashed with 10% acetic acid) in 2.5% formic acid 
and 7.5% acetic acid, pH 1.9, for 10 min at V/cm, 
followed by 40 min at 60 V/cm. Non-radioactive peaks 
were developed by using Pauli and ninhydrin reagents. 
The peaks were eluted with 10% acetic acid, lyophi- 
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lized, subjected to hydrolysis (6 M HCI, 18 h, 110°C) 
and analyzed for amino acid content using a Beckman 
Spinco Model 12OC Amino Acid Analyzer. 
2.3. Determination of M, 
. Enzymic preparations derived from anterior pitu- 
itaries or hypothalami (150 mg wet wt. tissue) were 
gel filtrated on a Sephadex G-200 superfine column 
(2.5 X 70 cm) and eluted continuously with 10 mM 
phosphate buffer (pH 6.8) at a flow rate of 2 ml/h. 
The fractions eluted from the column were tested for 
enzyme activity. The column was calibrated by the 
following proteins. immunoglobulin, bovine serum 
albumin and ovalbumin. 
3. Results 
Incubation of GnRH with the 100 000 X g super- 
natant fraction of the homogenates from rat anterior 
pituitaries resulted in loss of the immunoreactivity as 
well as hormonal activity of the decapeptide. Using 
isolation and identification methods for the products 
of the enzymic degradation of GnRH, it was found 
that the preferred site of cleavage of GnRH by the 
pituitary enzyme was the Gly6-Leu’ bond. The super- 
natant fractions ofthe pituitary glands were incubated 
for 10 min with [3H] GnRH diluted with unlabeled 
hormone. Electrophoresis of an aliquot of the incuba- 
tion reactions (pH 1.9) revealed 7 different peaks 
(fig.1). 3 peaks (I-III) were radioactive, fluorescent 
and gave positive test with Pauli’s reagent; peak II 
was also ninhydrin positive. The various peak regions 
were eluted from the paper with 10% acetic acid and 
the eluate was subjected to hydrolysis and amino acid 
analysis. Peak I was found to contain glutamic acid, 
histidine, serine, tyrosine and glycine in an apparent 
molar ratio of 1.2: 1 .O: 1.0:0.97:0.8,respectively. Peak 
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Fig.1. Electropherogram of the degradation products of GnRH. 
P., Pauli positive; N., ninhydrin positive. 
PH 
Fig.2. pH dependence of enzyme activity. B---e, pituitary 
enzyme; o---o, hypothalamic enzyme. 
II had the same amino acid composition, with a molar 
ratio of 1.25: 1.0:0.74:0.88: 1 .l , respectively, and its 
higher mobility might be due to an opening of the 
pyroglutamic ring. The third component (III) was 
identical to an authentic GnRH marker in amino acid 
composition and mobility. Of the 4 non-radioactive 
but ninhydrin-positive components, only region V had 
a composition which resembled a fragment of GnRH. 
It contained leucine, arginine, proline and glycine in 
a molar ratio of 0.92: 1.06: 1 .Ol : 1 .OO, respectively. 
The inactivation of GnRH was time dependent and 
was proportional to the amount of enzyme preparation 
used. Equivalents of 0.6, 1.5 and 3.0 mg of wet wt. 
pituitary tissue caused 35.3 + 12.8%, 84.6 + 1.7% and 
94.6 + 0.5% degradation, respectively, of 1 .O pg GnRH 
after 1 h of incubation at 37°C. The following experi- 
ments were carried out under selected conditions 
(amount of enzyme and time of reaction) where about 
50-60% of the substrate was degraded. This extent 
of degradation was arbitrarily defined as 100% and 
experimental effects (e.g. temperature, pH and inhib- 
itors) were expressed relatively to this value. 
The degradation reaction was pH and temperature 
dependent as illustrated in figs.2,3. Maximal proteo- 
lytic activity was evident in the pH range of 7.0-8.0 
(fig.2) and at 37’C (fig.3) for both the hyporhalamic 
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Fig.3. Temperature dependence of enzyme activity. o-0, 
pituitary enzyme; o---o, hypothalamic enzyme. 
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Fig.4. Chromatography of GnRHdegrading enzyme on 
Sephadex G-200. For experimental details see section 2. 
and the pituitary enzymes. The elution patterns of the 
enzyme preparations, from both hypothalamus and 
anterior pituitary gland on a precalibrated Sephadex 
G-200 column, indicated a J4, of 67 000 f 3000 for 
both enzymes (fig.4). Several enzyme inhibitors were 
examined for their ability to inhibit GnRH degradation. 
Non-active were the chelating reagents, 1 JO-phenan- 
troline and EDTA ( 10e3 M), trypsin and chymotrypsin 
blockers (TPCK, soybean trypsin inhibitor and benza- 
midine). Active reagents are enumerated in table 1. 
4. Discussion 
Relatively little is known about the mechanisms 
that regulate the secretion and the action of GnRH. 
Since both the hypothalamus and the pituitary gland 
Table 1 
Effect of various reagents on hypothalamic and anterior 
pituitary degrading enzymes 
Reagenta Concentration (M) required 
for 50% inhibition of GnRH 
degradationb 
Hypothalamus Pituitary 
Diisopropylfluorophosphate 3.3 x 1o-6 4.0 x 1o-6 
pChloromercuribenzoate 8.2 X 1O-6 9.9 x 1o-6 
N-Ethylmaleimide 1.2 x 1o-5 1.6 x lo-’ 
a AU reagents were dissolved immediately before use 
b Assays of degradation were performed as described in sec- 
tion 2 
contain enzymes that can degrade the neurohormone, 
it is possible that GnRH degradation participates in 
these processes. Changes in the activity of the GnRH- 
degrading enzymes were demonstrated after castration 
and replacement herapy with gonadal steroids [4-61. 
High concentrations of dopamine have been demon- 
strated to enhance the degradation of GnRH upon its 
incubation with synaptosomes derived from the hypo- 
thalamus [7]. Substitution of the glycine at position 
6 of GnRH by dextrarotatory amino acids results in 
analogues that are more potent and more resistant to 
enzymic degradation than GnRH itself [&lo]. 
Here, we examined the pattern of GnRH degrada- 
tion by the 100 000 X g supernatant fraction of ante- 
rior pituitary homogenates. Electrophoresis of the 
incubation products, followed by hydrolysis and amino 
acid analysis suggested that the inactivation of GnRH 
by the pituitary was due to cleavage of the Gly6-Leu7 
bond of the neurohormone similar to previous findings 
with the hypothalamic tissue [ 1 ,111. Supporting evi- 
dence for this assumptions is the formaton of the hexa- 
peptide pGlu-His-Trp-Ser-Tyr-Gly as the major radio- 
active product of [pyrogZ~tumyZ-3-3H]GnRH and the 
formation of the tetrapeptide Leu-ArgPro-Gly-NH*. 
The opening of the pyroglutamyl ring (fig. 1, second 
component) must have occurred only after the initial 
degradation of GnRH and the formation of the N-ter- 
minal hexapeptide, since the only decapeptide that 
was detected was intact GnRH. 
Additional evidence suggests that the GnRH-degrad- 
ing enzymes of the hypothalamus and of the anterior 
pituitary are very similar, if not identical. Both have 
identical M,-values (67 000), optimal activity at pH 
7.0-8.0 and at 37°C. The neutral pH optimum sug- 
gests that these enzymes are not lysozomal cathepsins. 
The two enzymes were inhibited by bacitracin [ 121 
and by crude preparations of kallikrein inactivator 
[ 1 ,131. The enzymes were also inhibited by specific 
reagents for serine and thiol peptidases (table l), sug- 
gesting the presence of serine or cysteine near or at 
the active site of the enzymes. The enzymes were not 
inhibited by metal-chelating reagents indicating that 
there are no metal requirements for the activity of 
the enzymes. 
It seems likely that G&H-degrading enzymes in 
the cytosolic fraction of the pituitary and the hypo- 
thalamus [ 1,8,1 l] as well as pituitary plasma mem- 
brane-associated enzymes [ 14,151 may act as a quench- 
ing mechanism that regulates the concentration and 
the activity of GnRH at the receptor site. 
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